Skip to content
No results
  • Archive
  • Health Medicine Network
  • index.html
  • Privacy policy
health medicine network
healthmedicinet
  • Health A-Z
  • Conditions-Procedures
  • Drugs & Supplements
    • Drugs
    • Herbs and Supplements
  • Interactive Tools
    • Animations of Medical Conditions
    • Health Calculators
    • Flash Interactive Tools
    • Medical Podcasts
    • Health Risk Assessments
    • Medical Quizzes
    • Medical Vodcasts
    • Clinical Wizards and Videos
  • Health News
health medicine network
healthmedicinet

Merck halts trial of once ‘promising’ Alzheimer’s drug

  • healthmedicinethealthmedicinet
  • February 16, 2017
  • news

Poor performance on a simple odor identification test was associated with a significantly increased risk of developing dementia years later, in a study of more than 2,400 older black and white adults led by Kristine Yaffe, …

Related posts:

  1. HMN 2025: How NU-9 halts Alzheimer’s disease in animal model before symptoms begin
  2. HMN 2025: How An FDA-approved drug halts Epstein-Barr virus-driven lymphoma by disrupting a key cancer pathway
  3. HMN 2025: How Analysis of NRG trial in limited-stage small cell lung cancer suggests QOL benefit with twice- vs. once-daily radiation
  4. HMN 2025: How Once-weekly eloralintide leads to 20% weight loss in Phase II trial
Previous Post Are Baked Lay’s potato chips "guilt-free"? PepsiCo says so
Next Post Dermoscopy + triple light source reliable in ID of pityriasis rosea

Copyright © 2026  Healthmedicinet.com